Access, affordability, remains the No
Safety data in special populationssuch as pregnant or lactating women, pediatric patients, and those with advanced renal or hepatic impairmentremain limited and require further study
, Dalboge, L
GLP-1 Medications reduce physical hunger and food noise, however they dont rewrite the thoughts, emotions, and behaviors built around food over a lifetime
The previous three were all in moderate to severe plaque psoriasis, where Bimzelx already demonstrated superiority over: - Cosentyx (secukinumab) by Novartis - Stelara (ustekinumab) by Johnson & Johnson - Humira (adalimumab) by AbbVie Three of the biggest selling biologics in the world
without type 2 diabetes: HR, 1.18 [95% CI, 1.13-1.22])